MDPP at utilization nadir as new flexibilities aim for a kickstart
The COVID-19 pandemic appears to have severely hit the Medicare Diabetes Prevention Program (MDPP) in 2020, with claims dropping to less than half of what they were in 2019. The decreased volume comes despite a range of CMS flexibilities and marks another ominous sign for the underperforming program.
To read the full article, sign in and subscribe to the DecisionHealth Newsletters.